FDA.reportPublic FDA data

Trelstar 22.5 MG Injection

RxCUI
905057
RxNorm name
Trelstar 22.5 MG Injection
Display name
Trelstar 22.5 MG Injection
Full name
Trelstar 22.5 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TrelstarTRIPTORELIN PAMOATEVerity Pharmaceuticals Inc.b1b84d62-a369-a4b7-5c41-dd1f553a18f32026-06-30Warnings, Adverse reactionsExact identifier
rxcui: 905057

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b1b84d62-a369-a4b7-5c41-dd1f553a18f3Trelstar 22.5 MG Injection [PSN] · triptorelin 22.5 MG Injection [Trelstar] [SBD] · Trelstar 22.5 MG Injection [SY]318These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. TRELSTAR ® (triptorelin pamoate for injectable suspension), for intramuscular use Initial U.S. Approval: 200020250923